SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs quarterly earnings report is the focal point, with traders watching guidance, subscriber engagement, advertising growth, and content strategy amid leadership changes and layoffs. Bearish concerns about competition, content quality, and slowing growth contrast with bullish hopes that low expectations and ad expansion could support a positive reaction.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Modernas rally is drawing attention as traders position around the full Phase 3 melanoma cancer-vaccine data presentation at ESMO, following previously reported positive topline results. Bulls see the readout as validation of the oncology pipeline, while skeptics warn that expectations and valuation are elevated and debate whether the event could prompt profit-taking.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

SRPTs sharp rebound is drawing attention, with traders attributing the move to possible short covering and technical buying rather than a confirmed new company announcement. The broader debate centers on upcoming DM1 and FSHD siRNA data: Novartis/Aviditys DM1 trial failure raised concerns about whether target knockdown can translate into patient benefit, while some traders argue Sareptas distinct delivery approach and the loss of a competitor could be favorable.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Sea shares are falling amid concern over plans to list its Monee financial-services arm and launch Sea Cloud, which traders worry could add spending and strategic uncertainty. The community is split between viewing a Monee separation as a potential value unlock and fearing it could weaken the remaining business, while some see the selloff as an overreaction.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GM is selling off despite a third-quarter earnings beat and a new buyback authorization, as traders focus on narrowed full-year profit guidance with an unchanged midpoint and weaker vehicle sales. Some view the drop as overdone given the stronger cash-flow outlook and buyback, while others see the outlook as too cautious to offset the earnings-day disappointment.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE Aerospaces earnings beat and raised outlook drew attention as shares sold off despite strong demand, with traders frustrated by the reaction. The debate centers on whether higher costs, weaker cash generation and an insurance loss outweigh the stronger orders and guidance.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Attention is centered on TG Therapeutics MSToronto presentations, especially initial Phase 1 azer-cel results in progressive MS, alongside new BRIUMVI data. Traders are hopeful azer-cel could add a growth opportunity beyond BRIUMVI, while recognizing the early readouts efficacy is uncertain; continued BRIUMVI sales growth is the more established part of the story.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizers push to a fresh 52-week high is drawing attention, with traders celebrating a long-awaited recovery and debating whether the breakout can hold or will meet resistance. Some point to defensive-sector demand and pipeline progress, while others say the move needs a clearer company-specific catalyst.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports Phase 2 RAP-219 trial in bipolar mania met its primary and secondary endpoints, driving attention to the drugs potential and analyst optimism. Traders are debating whether the placebo-adjusted benefit is modest and whether agitation concerns and higher discontinuations could limit the upside, with some viewing the move as vulnerable to a fade.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriad Genetics agreement to sell its prenatal testing business to Labcorp is driving a sharp rally, with traders viewing the cash proceeds as a balance-sheet and strategic boost. Others question the deal because the divested unit contributes revenue, raising concerns about debt and the outlook for the remaining business; some traders are also taking profits after the surge.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Today's Stolen Data Could Be Tomorrow's Decrypted Data

Today's Stolen Data Could Be Tomorrow's Decrypted Data Today's Stolen Data Could Be Tomorrow's Decrypted DataPR NewswireVANCOUVER, BC, Sept. 25, 2026 VANCOUVER, BC, Sept. 25, 2026 /PRNewswire/ -- Equity Insider News Commentary - Some of the most sensitive data intercepted today may not be read for...

Satellites Built Today Must Outlive the Encryption Protecting Them

Satellites Built Today Must Outlive the Encryption Protecting Them Satellites Built Today Must Outlive the Encryption Protecting ThemPR NewswireVANCOUVER, BC, Sept. 17, 2026 VANCOUVER, BC, Sept. 17, 2026 /PRNewswire/ -- Equity Insider News Commentary A satellite launched this year may still be...

Global Post-Quantum Cryptography Market Size Projected to Reach $2.84 Billion By 2030

Global Post-Quantum Cryptography Market Size Projected to Reach $2.84 Billion By 2030 Global Post-Quantum Cryptography Market Size Projected to Reach $2.84 Billion By 2030 PR Newswire VANCOUVER, BC, Aug. 19, 2026 VANCOUVER, BC, Aug. 19, 2026 /PRNewswire/ -- USA News Group News Commentary- The...

The Zacks Analyst Blog Highlights Quantinuum, IonQ, NVIDIA, IBM, QTUM, ARQQ, WQTM and CHPX

Quantum ETFs are gaining momentum as AI strains classical computing, with federal funding and breakthroughs fueling the sector's growth.

The Next AI Surge: Top Quantum ETFs to Buy Amid Washington's Funding Push

Quantum ETFs are gaining momentum as U.S. funding and breakthroughs accelerate the sector, offering investors diversified exposure to its growth.

You Cannot Protect What You Cannot See: A Cybersecurity Company Just Built a Map for the Encryption Hiding Inside Your Business

You Cannot Protect What You Cannot See: A Cybersecurity Company Just Built a Map for the Encryption Hiding Inside Your Business You Cannot Protect What You Cannot See: A Cybersecurity Company Just Built a Map for the Encryption Hiding Inside Your Business PR Newswire VANCOUVER, BC, July 28, 2026...

The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel

The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel PR Newswire VANCOUVER, BC, July 6, 2026 A wave of government...

12 Information Technology Stocks Moving In Tuesday's Intraday Session

Gainers

Backblaze (NASDAQ:BLZE) stock rose 38.3% to $11.23 during Tuesday's regular session. The market value of their outstanding shares is at $487.3 million.
Arqit Quantum (NASDAQ:ARQQ) stock moved upwards byread more...

ARQQ Stock On Track For A Four-Month High – What’s Driving The Rally? 

Equity

The company settled a lawsuit filed against it in June 2022 by agreeing to pay the plaintiffs.

The Quiet Race to Rewire the World's Encryption Before Quantum Computers Break It

The Quiet Race to Rewire the World's Encryption Before Quantum Computers Break It The Quiet Race to Rewire the World's Encryption Before Quantum Computers Break It PR Newswire VANCOUVER, BC, June 17, 2026 Issued on behalf of Quantum Secure Encryption Corp.As governments set hard deadlines to...

Arqit Quantum, Inc. engages in the provision of cybersecurity services via satellite and terrestrial forms. Its product is QuantumCloud which secures devices with cloud-based quantum encryption. The company was founded by David John Williams and David James Bestwick on April 26, 2021 and is headquartered in London, the United Kingdom.

Arqit Quantum Inc

Neutral Sentiment

<ul class="summary-bullets"><li>The suit alleged that cybersecurity company Arqit failed to disclose certain crucial conditions for its technology and products to function.</li><li>The company made misrepresentations about its revenue sources when it listed on the Nasdaq, per the lawsuit.&nbsp;</li><li>Arqit agreed to pay $7 million to settle the lawsuit.</li></ul><p>Shares of Arqit Quantum (ARQQ) are rising on Wednesday after the company settled a previously filed lawsuit against it and its directors, eliminating the burden of legal uncertainty it has faced over the last four years.</p><p>At the time of writing, ARQQ stock was up 14%, on track for an over four-month high if session gains hold, and among the top ten trending tickers on Stocktwits.</p><h1 class="st-heading-1"><strong>Why Was The Lawsuit Filed?</strong></h1><p>Among other things, the suit alleged that Arqit claimed to be a cybersecurity company with unique quantum encryption technology capable of staving off future cyberattacks, including those from quantum computers. However, it did not disclose factors such as the need for widespread adoption of new telecommunications protocols and infrastructure.</p><p>Arqit also claimed to have already signed major, long-term contracts for its services with large companies and government institutions before going public. But a Wall Street Journal investigation found that the company's revenue consisted of only a handful of government grants and small research contracts when it listed on the Nasdaq.</p><h1 class="st-heading-1"><strong>The Settlement</strong></h1><p>The company disclosed in an SEC filing on Wednesday that a federal court has approved the settlement agreement between the company, its directors, and the plaintiff who filed the case.</p><p>As part of the settlement, Arqit will pay $7 million, thereby resolving all class actions filed against it in the U.S.</p><p>The lawsuit is Robert Glick v. Arqit Quantum Inc., Case No. 1:22-cv-02604, filed in the United States District Court, Eastern District of New York on June 5, 2022.</p><h1 class="st-heading-1"><strong>What Do Retail Traders Think About ARQQ?</strong></h1><p>On Stocktwits, retail sentiment toward ARQQ stock turned ‘extremely bullish’ from ‘bullish’ over the last 24 hours, amid ‘extremely high’ message volumes.</p><p><a href="https://stocktwits.com/symbol/ARQQ">ARQQ stock</a> has fallen 3% so far this year and has declined nearly 37% over the last 12 months.</p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, the Arqit Quantum logo is seen displayed on a smartphone screen. (Source: Getty Images)

Shares of Arqit Quantum (ARQQ) are rising on Wednesday after the company settled a previously filed lawsuit against it and its directors, eliminating the burden of legal uncertainty it has faced over the last four years.

Yes, still bullish

No, losing confidence

Waiting to see earnings first

Never was bullish

Quantum computing stocks - like $IONQ, $RGTI, and $QBTS - were very popular in 2025, but the sector remains pre-profit and highly speculative. Are you still bullish on quantum?

Stocktwits

IonQ Inc

Rigetti Computing Inc

D-Wave Quantum Inc

 - were very popular in 2025, but the sector remains pre-profit and highly speculative. Are you still bullish on quantum?

Current Price	$15.05
Prev Close	$14.02
Open	$13.58
Dividend Yield	0.00%
50-Day Moving Average	$20.94
Beta	2.55
Avg. Volume	380,932.41
PE Ratio	-4.41

52-Week High	$49.33
52-Week Low	$11.52
Market Capitalization	$243.98M
EPS (Annual)	-$2.56
Price to Book	8.16
Revenue Per Employee	$5,824.18

Feed

News

Sentiment

Earnings

Fundamentals

Info

ARQQ Fundamentals